
Vivani Medical Inc
NASDAQ:VANI

Balance Sheet
Balance Sheet Decomposition
Vivani Medical Inc
Current Assets | 20.4m |
Cash & Short-Term Investments | 18.4m |
Receivables | 253k |
Other Current Assets | 1.8m |
Non-Current Assets | 21.1m |
Long-Term Investments | 131k |
PP&E | 19.7m |
Other Non-Current Assets | 1.3m |
Balance Sheet
Vivani Medical Inc
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
16
|
11
|
8
|
4
|
11
|
3
|
70
|
45
|
21
|
18
|
|
Cash |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
16
|
10
|
7
|
4
|
11
|
3
|
70
|
45
|
21
|
18
|
|
Total Receivables |
2
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
2
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
8
|
3
|
3
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
1
|
1
|
1
|
1
|
0
|
1
|
1
|
2
|
2
|
2
|
|
Total Current Assets |
27
|
15
|
13
|
10
|
13
|
4
|
71
|
48
|
23
|
20
|
|
PP&E Net |
1
|
1
|
1
|
1
|
3
|
0
|
0
|
2
|
21
|
20
|
|
PP&E Gross |
1
|
1
|
1
|
1
|
3
|
0
|
0
|
2
|
21
|
20
|
|
Accumulated Depreciation |
5
|
2
|
3
|
3
|
4
|
0
|
1
|
2
|
2
|
3
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Total Assets |
28
N/A
|
17
-40%
|
15
-14%
|
11
-26%
|
17
+55%
|
4
-73%
|
71
+1 489%
|
51
-28%
|
46
-10%
|
42
-9%
|
|
Liabilities | |||||||||||
Accounts Payable |
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
Accrued Liabilities |
5
|
4
|
6
|
6
|
6
|
2
|
2
|
6
|
5
|
5
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
8
|
6
|
7
|
8
|
7
|
5
|
2
|
7
|
6
|
6
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
19
|
18
|
|
Total Liabilities |
8
N/A
|
6
-29%
|
7
+17%
|
8
+15%
|
9
+23%
|
5
-45%
|
3
-51%
|
7
+172%
|
25
+267%
|
24
-4%
|
|
Equity | |||||||||||
Common Stock |
166
|
187
|
202
|
229
|
264
|
270
|
348
|
109
|
0
|
0
|
|
Retained Earnings |
173
|
206
|
234
|
269
|
305
|
320
|
329
|
73
|
98
|
122
|
|
Additional Paid In Capital |
27
|
31
|
41
|
44
|
49
|
49
|
49
|
8
|
119
|
139
|
|
Other Equity |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
20
N/A
|
11
-45%
|
8
-29%
|
3
-61%
|
7
+136%
|
1
N/A
|
68
N/A
|
44
-35%
|
21
-53%
|
18
-15%
|
|
Total Liabilities & Equity |
28
N/A
|
17
-40%
|
15
-14%
|
11
-26%
|
17
+55%
|
4
-73%
|
71
+1 489%
|
51
-28%
|
46
-10%
|
42
-9%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
2
|
2
|
2
|
3
|
5
|
8
|
13
|
51
|
51
|
59
|